What AREDS2 actually is

AREDS2 (Age-Related Eye Disease Study 2) was a large clinical trial funded by the U.S. National Eye Institute, part of the National Institutes of Health. It tested a specific nutrient formula in over 4,000 participants who already had intermediate or advanced age-related macular degeneration (AMD) in at least one eye.

It followed an earlier trial, AREDS1, and ran for about five years, with participants tracked for even longer afterward. This is a different level of evidence than most vision supplements have behind them — most are supported by small studies, animal research, or nothing specific to eye disease at all.

What the research actually shows

The tested formula contains specific, high doses of six nutrients:

• Vitamin C — 500 mg
• Vitamin E — 400 IU
• Zinc — 80 mg (as zinc oxide)
• Copper — 2 mg (added specifically to offset the high zinc dose, which can otherwise cause copper deficiency)
• Lutein — 10 mg
• Zeaxanthin — 2 mg

For people with intermediate AMD, this specific combination, at these specific doses, measurably slowed progression toward vision-threatening advanced disease. That’s a real, replicated, government-funded finding. Supported

The benefit was shown in people who already had intermediate AMD — not as general prevention for people with healthy eyes.

What it does not show

• It does not show that this formula prevents AMD from starting in someone who doesn’t have it.
• It does not show benefit for early-stage AMD — the trial specifically enrolled people with intermediate or advanced disease.
• It does not reverse vision loss that has already occurred.
• It does not show benefit for other eye conditions — cataracts, glaucoma, or general “eye strain” — despite how often it’s marketed that way.
• It does not show that lower doses, or the same ingredients mixed with a dozen other things, produce the same effect. The trial tested this exact formula at these exact doses.

If a product markets “AREDS2-inspired” ingredients without matching the actual doses, it’s borrowing credibility from a trial it didn’t replicate. Check The Dose

Why beta-carotene was removed

The original AREDS1 formula included beta-carotene (a form of vitamin A). AREDS2 specifically tested removing it and replacing it with lutein and zeaxanthin — because separate research had linked beta-carotene supplementation to an increased risk of lung cancer in smokers and former smokers.

AREDS2 confirmed that lutein and zeaxanthin worked at least as well, without that risk. Since then, beta-carotene is generally considered the outdated, higher-risk version of this formula — current guidance favors the lutein/zeaxanthin version, especially for anyone who smokes or used to.